Background. Tricuspid valve regurgitation (TR) after orthotopic heart transplantation (OHT) is common. The aims of this study were to determine the prevalence of TR after OHT, to examine the correlation between its development and various variables, and to determine its outcomes. Methods. All 163?OHT patients who were followed up between 1988 and 2009 for a minimal period of 12 months were divided into those with no TR/mild TR and those with at least mild-moderate TR, as assessed by doppler echocardiography. These groups were compared regarding preoperative hemodynamic variables, surgical technique employed, number of endomyocardial biopsies, number of acute cellular rejections, incidence of graft vasculopathy, and clinical outcomes. Results. At the end of the followup (average 8.2 years) significant TR was evident in 14.1% of the patients. The development of late TR was found by univariate, but not multivariate, analysis to be significantly correlated with the biatrial surgical technique ( ) and the presence of graft vasculopathy ( ). TR development was found to be correlated with the need for tricuspid valve surgery but not with an increased mortality. Conclusions. The development of TR after OHT may be related to the biatrial anastomosis technique and to graft vasculopathy. 1. Introduction Tricuspid regurgitation (TR) after orthotopic heart transplantation (OHT) is common, with reported prevalence that varies from 19% to 84% [1]. The prevalence and severity of TR increase with the length of followup. In most cases TR is mild and asymptomatic, but some cases of moderate or severe TR are related to morbidity and mortality [1–5]. Doppler echocardiography is the most common technique used for the detection and evaluation of severity of TR [6, 7]. The treatment of severe symptomatic TR is mainly conservative with diuretics. In refractory cases there is an indication for tricuspid valve repair or replacement surgery. The etiology of TR after OHT is unclear, and several variables have been reported to be related, including the surgical anastomosis technique employed (biatrial versus bicaval) [8–13], iatrogenic damage due to endomyocardial biopsies (EMBs) [8, 14–18], number of acute cellular rejection episodes (ACRs) [8, 14], pretransplant pulmonary hypertension [8, 19, 20], discordance between the size of the donor’s heart and the recipient’s pericardial cavity [21], and cardiac allograft vasculopathy (CAV) [14]. Preventive measures mentioned in the literature include prophylactic tricuspid annuloplasty during OHT [22–24], the use of a long bioptome sheath
References
[1]
R. C. C. Wong, Z. Abrahams, M. Hanna et al., “Tricuspid regurgitation after cardiac transplantation: an old problem revisited,” Journal of Heart and Lung Transplantation, vol. 27, no. 3, pp. 247–252, 2008.
[2]
T. M. Aziz, R. A. Saad, M. I. Burgess, C. S. Campbell, and N. A. Yonan, “Clinical significance of tricuspid valve dysfunction after orthotopic heart transplantation,” Journal of Heart and Lung Transplantation, vol. 21, no. 10, pp. 1101–1108, 2002.
[3]
M. C. Y. Chan, N. Giannetti, T. Kato et al., “Severe tricuspid regurgitation after heart transplantation,” Journal of Heart and Lung Transplantation, vol. 20, no. 7, pp. 709–717, 2001.
[4]
D. Marelli, F. Esmailian, S. Y. Wong et al., “Tricuspid valve regurgitation after heart transplantation,” Journal of Thoracic and Cardiovascular Surgery, vol. 137, no. 6, pp. 1557–1559, 2009.
[5]
G. Sahar, A. Stamler, E. Erez et al., “Etiological factors influencing the development of atrioventricular valve incompetence after heart transplantation,” Transplantation Proceedings, vol. 29, no. 6, pp. 2675–2676, 1997.
[6]
W. A. Zoghbi, M. Enriquez-Sarano, E. Foster et al., “Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography,” Journal of the American Society of Echocardiography, vol. 16, no. 7, pp. 777–802, 2003.
[7]
A. Mugge, W. G. Daniel, G. Herrmann, R. Simon, and P. R. Lichtlen, “Quantification of tricuspid regurgitation by Doppler color flow mapping after cardiac transplantation,” American Journal of Cardiology, vol. 66, no. 10, pp. 884–887, 1990.
[8]
T. M. Aziz, M. I. Burgess, A. N. Rahman, C. S. Campbell, A. K. Deiraniya, and N. A. Yonan, “Risk factors for tricuspid valve regurgitation after orthotopic heart transplantation,” Annals of Thoracic Surgery, vol. 68, no. 4, pp. 1247–1251, 1999.
[9]
R. De Simone, R. Lange, F. U. Sack, H. Mehmanesh, and S. Hagl, “Atrioventricular valve insufficiency and atrial geometry after orthotopic heart transplantation,” Annals of Thoracic Surgery, vol. 60, no. 6, pp. 1686–1693, 1995.
[10]
A. Koch, A. Remppis, T. J. Dengler, P. A. Schnabel, S. Hagl, and F. U. Sack, “Influence of different implantation techniques on AV valve competence after orthotopic heart transplantation,” European Journal of Cardio-Thoracic Surgery, vol. 28, no. 5, pp. 717–723, 2005.
[11]
J. P. Sun, J. Niu, M. K. Banbury et al., “Influence of different implantation techniques on long-term survival after orthotopic heart transplantation: an echocardiographic study,” Journal of Heart and Lung Transplantation, vol. 26, no. 12, pp. 1243–1248, 2007.
[12]
K. Y. Park, C. H. Park, Y. B. Chun, M. S. Shin, and K. C. Lee, “Bicaval anastomosis reduces tricuspid regurgitation after heart transplantation,” Asian Cardiovascular and Thoracic Annals, vol. 13, no. 3, pp. 251–254, 2005.
[13]
M. Schnoor, T. Sch?fer, D. Lühmann, and H. H. Sievers, “Bicaval versus standard technique in orthotopic heart transplantation: a systematic review and meta-analysis,” Journal of Thoracic and Cardiovascular Surgery, vol. 134, no. 5, pp. 1322–1331, 2007.
[14]
B. Hausen, J. M. Albes, R. Rohde, S. Demertzis, A. Mügge, and H. J. Sch?fers, “Tricuspid valve regurgitation attributable to endomyocardial biopsies and rejection in heart transplantation,” Annals of Thoracic Surgery, vol. 59, no. 5, pp. 1134–1140, 1995.
[15]
C. Y. Lo, H. H. Chang, C. P. Hsu, S. T. Lai, and C. C. Shih, “Endomyocardial biopsy-related tricuspid regurgitation after orthotopic heart transplantation: single-center experience,” Journal of the Chinese Medical Association, vol. 70, no. 5, pp. 185–192, 2007.
[16]
V. Nguyen, M. Cantarovich, R. Cecere, and N. Giannetti, “Tricuspid regurgitation after cardiac transplantation: how many biopsies are too many?” Journal of Heart and Lung Transplantation, vol. 24, supplement 7, pp. S227–S231, 2005.
[17]
L. Mielniczuk, H. Haddad, R. A. Davies, and J. P. Veinot, “Tricuspid valve chordal tissue in endomyocardial biopsy specimens of patients with significant tricuspid regurgitation,” Journal of Heart and Lung Transplantation, vol. 24, no. 10, pp. 1586–1590, 2005.
[18]
M. J. A. Williams, M. Y. Lee, T. G. DiSalvo et al., “Biopsy-induced flail tricuspid leaflet and tricuspid regurgitation following orthotopic cardiac transplantation,” American Journal of Cardiology, vol. 77, no. 15, pp. 1339–1344, 1996.
[19]
S. J. S. Bhatia, J. M. Kirshenbaum, R. J. Shemin et al., “Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation,” Circulation, vol. 76, no. 4, pp. 819–826, 1987.
[20]
M. K. Lewen, R. J. Bryg, and L. W. Miller, “Tricuspid regurgitation by Doppler echocardiography after orthotopic cardiac transplantation,” American Journal of Cardiology, vol. 59, no. 15, pp. 1371–1374, 1987.
[21]
A. Haverich, J. M. Albes, G. Fahrenkamp, H. J. Sch?fers, T. Wahlers, and B. Heublein, “Intraoperative echocardiography to detect and prevent tricuspid valve regurgitation after heart transplantation,” European Journal of Cardio-Thoracic Surgery, vol. 5, no. 1, pp. 41–45, 1991.
[22]
N. E. Brown, G. F. Muehlebach, P. Jones, M. E. Gorton, R. S. Stuart, and A. M. Borkon, “Tricuspid annuloplasty significantly reduces early tricuspid regurgitation after biatrial heart transplantation,” Journal of Heart and Lung Transplantation, vol. 23, no. 10, pp. 1160–1162, 2004.
[23]
V. Jeevanandam, H. Russell, P. Mather, S. Furukawa, A. Anderson, and J. Raman, “Donor tricuspid annuloplasty during orthotopic heart transplantation: long-term results of a prospective controlled study,” Annals of Thoracic Surgery, vol. 82, no. 6, pp. 2089–2095, 2006.
[24]
A. I. Fiorelli, N. A. G. Stolf, C. A. C. Abreu Filho et al., “Prophylactic donor tricuspid annuloplasty in orthotopic bicaval heart transplantation,” Transplantation Proceedings, vol. 39, no. 8, pp. 2527–2530, 2007.
[25]
A. C. Yankah, M. Musci, Y. Weng et al., “Tricuspid valve dysfunction and surgery after orthotopic cardiac transplantation,” European Journal of Cardio-Thoracic Surgery, vol. 17, no. 4, pp. 343–348, 2000.
[26]
S. Stewart, G. L. Winters, M. C. Fishbein et al., “Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection,” Journal of Heart and Lung Transplantation, vol. 24, no. 11, pp. 1710–1720, 2005.
[27]
R. J. C. Chen, J. Wei, C. Y. Chang et al., “Tricuspid valve regurgitation and endomyocardial biopsy after orthotopic heart transplantation,” Transplantation Proceedings, vol. 40, no. 8, pp. 2603–2606, 2008.
[28]
C. B. Huddleston, M. Rosenbloom, J. A. Goldstein, and M. K. Pasque, “Biopsy-induced tricuspid regurgitation after cardiac transplantation,” Annals of Thoracic Surgery, vol. 57, no. 4, pp. 832–837, 1994.
[29]
J. Stehlik, L. B. Edwards, A. Y. Kucheryavaya et al., “The registry of the international society for heart and lung transplantation: twenty-eighth adult heart transplant report-2011,” Journal of Heart and Lung Transplantation, vol. 30, no. 10, pp. 1178–1194, 2011.